MEDIMI — Medimi AB Income Statement
0.000.00%
Last trade - 00:00
- SEK16.86m
- SEK7.55m
- SEK3.64m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.17 | 0.573 | 1.08 | 2.08 | 3.64 |
Cost of Revenue | |||||
Gross Profit | -0.945 | -0.689 | -0.628 | 0.569 | 2.04 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13.3 | 14.1 | 17.4 | 17.4 | 17.8 |
Operating Profit | -12.1 | -13.6 | -16.3 | -15.4 | -14.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -12.1 | -13.6 | -16.4 | -15.4 | -14.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.1 | -13.6 | -16.4 | -15.4 | -14.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -12.1 | -13.6 | -16.4 | -15.4 | -14.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.1 | -13.6 | -16.4 | -15.4 | -14.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.039 | -0.05 | -0.05 | -0.028 | -0.014 |
Dividends per Share |